N@N

DHIL, DRH, CHTP, PSEM, ITMN, KRG Expected to Trade Up After Bullish Patterns Develop

April 20, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. DIAMOND HILL INVESTMENT GRP (NASDAQ:DHIL), DIAMONDROCK HOSPITALITY CO (NYSE:DRH), CHELSEA THERAPEUTICS INTERNA (NASDAQ:CHTP), PERICOM SEMICONDUCTOR CORP (NASDAQ:PSEM), INTERMUNE INC (NASDAQ:ITMN), KITE REALTY GROUP TRUST (NYSE:KRG) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                            Pattern Name            Strength  
     DHIL       DIAMOND HILL INVESTMENT GRP         Breakout (Stocks) DO                Broadening Reversal     1         
     DRH        DIAMONDROCK HOSPITALITY CO          Reversal (Stocks) DWC               Trend Line Reversal(3)     1         
     CHTP       CHELSEA THERAPEUTICS INTERNA        Breakout (Stocks) DO                Trend Line Break(3)     5         
     PSEM       PERICOM SEMICONDUCTOR CORP          Reversal (Stocks) DWC               Trend Line Break(2)     1         
     ITMN       INTERMUNE INC                       Trending (Stocks) DO                Broadening Top          4         
     KRG        KITE REALTY GROUP TRUST             Reversal (Stocks) DWC               Trend Line Break(2)     1         

Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

DIAMOND HILL INVESTMENT GRP (NASDAQ:DHIL) - Diamond Hill Investment Group, Inc., through its subsidiaries, sponsors, markets, and provides investment advisory and related services in the United States. It also provides underwriting, compliance, treasury, and fund administration services to mutual fund companies. The company provides its services to various clients, including mutual funds, separate accounts, and private investment funds, as well as offers advisory services to institutional and individual investors. It distributes its products through financial intermediaries, including independent registered investment advisors, brokers, financial planners, investment consultants, and third party marketing firms. The company was founded in 1990 and is based in Columbus, Ohio.

DIAMONDROCK HOSPITALITY CO (NYSE:DRH) - DiamondRock Hospitality Company, a lodging focused real estate company, owns and operates premium hotels and resorts in North America. Its properties are located in New York City, Los Angeles, Chicago, Boston, and Atlanta; and in destination resort locations, such as the U.S. Virgin Islands, as well as Vail, Colorado. As of February 26, 2010, the company owned and operated 20 premium hotels and resorts with approximately 9,600 guestrooms. The company qualifies as a real estate investment trust (REIT) under the Internal Revenue Code. As a REIT, it would not be subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2004 and is based in Bethesda, Maryland.

CHELSEA THERAPEUTICS INTERNA (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

PERICOM SEMICONDUCTOR CORP (NASDAQ:PSEM) - Pericom Semiconductor Corporation designs, manufactures, and markets digital, analog, and mixed-signal integrated circuits (ICs) and frequency control products (FCPs) used in advanced electronic systems. Its products are used for transferring, routing, and timing of digital and analog signals within and between computer, networking, data communications, and telecommunications systems. The company offers SiliconConnect family products, including PCI and PCI-X bridges, PCI Express Bridges and packet switches, drivers, receivers, and transceivers, as well as low-voltage differential signaling products; SiliconSwitch family products comprising application-specific standard product switches, analog switches, and digital switches; SiliconInterface family products consisting of redrivers/signal conditioners, universal level shifters, lower balanced drives, application specific logic functions, 3.3-volt interface logic products, 5-volt FCT logic products, and gates; and SiliconClock family products, such as clock buffers and zero-delay clock drivers, voltage controlled crystal oscillators, clock frequency synthesizers, and programmable clocks. Its FCPs include crystals that resonate at a precise frequency, and crystal oscillators used in various electronic devices. The companys ICs and FCPs are used in various applications, such as notebook computers, servers, network switches and routers, storage area networks, digital TVs, cell phones, global positioning satellite systems, and digital media players. Pericom Semiconductor Corporation markets and distributes its products through a network of independent sales representatives and distributors to original equipment manufacturers and contract manufacturers in the computer, peripherals, networking, and telecommunications markets, as well as to end-user customers worldwide. The company was founded in 1990 and is headquartered in San Jose, California.

INTERMUNE INC (NASDAQ:ITMN) - InterMune, Inc., a biotech company, focuses on developing and commercializing therapies in pulmonology and hepatology primarily in the United States and Europe. The company primarily offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic granulomatous disease. Its pulmonology product portfolio includes lead product candidate, pirfenidone, a phase III product being developed for the treatment of patients with idiopathic pulmonary fibrosis; and a research program focused on small molecules for pulmonary diseases. The companys hepatology portfolio comprises the HCV protease inhibitor RG7227, a phase IIb chronic hepatitis C program and an early stage research program evaluating a new target in hepatology. It has license and collaboration agreements with Hoffmann-LaRoche Inc. and F. Hoffmann-LaRoche Ltd.; Genentech, Inc.; Boehringer Ingelheim International GmbH; Connetics Corporation; and Novartis Corporation. The company was founded in 1998 and is headquartered in Brisbane, California.

KITE REALTY GROUP TRUST (NYSE:KRG) - Kite Realty Group Trust, a real estate investment trust (REIT), engages in the acquisition, development, expansion, construction, ownership, leasing, operation, and management of neighborhood and community shopping centers, and commercial real estate properties in the United States. It also provides real estate facility management, construction, development, and other advisory services to third parties. As of March 31, 2008, the company owned interests in 57 operating properties consisting of 52 retail properties, 4 commercial properties, and 1 associated parking garage, as well as had 10 properties under development or redevelopment. Kite Realty Group qualifies as a REIT under the Internal Revenue Code. As a REIT, the company would not be subject to federal tax to the extent that it distributes at least 90% of its taxable income to its shareholders. Kite Realty Group was founded in 1968 and is based in Indianapolis, Indiana.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net